Revised Schedules including all amendments made
by the
Commission on Narcotic Drugs in force as of 1 July 1993*
LIST OF SUBSTANCS IN THE SCHEDULES
List of Substances in Schedule I
International nonproprietary name |
Other nonproprietary or trivial name |
Chemical name |
1. | BROLAMFETAMINE | DOB | (±)-4-bromo-2,5-dimethoxy-a- methylphenethylamine |
2. | CATHINONE | (-)-(S)-2-aminopropiophenone | |
3. | DET | 3-[2-(diethylamino)ethyl]indole | |
4. | DMA | (±)-2,5-dimethoxy-a-methyl- phenethylamine |
|
5. | DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10- tetrahydro-6,6,9-trimethyl-6H- dibenzo[b,d]pyran-1-ol |
|
6. | DMT | 3-[2-(dimethylamino)ethyl]indole | |
7. | DOET | (±)-4-ethyl-2,5-dimethoxy-a- phenethylamine |
|
8. | N-ETHYL- TENAMFETAMINE |
MDE, N-ETHYL- MDA |
(±)-N-ethyl-a-methyl-3,4- (methylenedioxy)phenethylamine |
9. | ETICYCLIDINE | PCE | N-ethyl-1-phenylcyclohexylamine |
10. | N-HYDROXY- TENAMFET- AMINE |
N-OH MDA, N-HYDROXY- MDA |
(±)-N-[a-methyl-3,4-(methylene- dioxy)phenethyl]hydroxyl- amine |
11. | (+)-LYSERGIDE | LDS, LSD-25 | 9,10-didehydro-N,N-diethyl-6- methylergoline-8ß-carboxamide |
12. | MDMA | (±)-N,a-dimethyl-3,4-(methylene- dioxy)phenethylarnine |
|
13. | mescaline | 3,4,5-trimethoxyphenethylamine | |
14. | 4-METHYLAMINO- REX |
(±)-cis-2-amino-4-methyl- 5-phenyl-2-oxazoline (±}-cis-4,5-dihydro-4-methyl- 5-phenyl-2-oxazolamine |
|
15. | MMDA | 2-methoxy-a-methyl-4,5- (methylenedioxy)phenethylamine |
|
16. | parahexyl | 3-hexyl-7,8,,9,10-tetrahydro-6,6,9- trimethyl-6H-dibenzo[b,d] pyran-1-ol |
|
17. | PMA | p-rnethoxy-a-methylphen- ethylamine |
|
18. | psilocine, psilotsin |
3-[2-(dimethylamino)ethyl] indol-4-ol |
|
19. | PSILOCYBINE | 3-[2-(dimethylamino)ethyl]indol-4- yl dihydrogen phosphate |
|
20. | ROLICYCLIDINE | PHP, PCPY | 1-(1-phenylcyclohexyl)pyrrolidine |
21. | STP, DOM | 2,5-dimethoxy-a,4-dimethyl- phenethylamine |
|
22. | TENAMFETAMINE | MDA | a-methyl-3,4(methylenedioxy) phenethylamine |
23. | TENOCYCLIDINE | TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine |
24. | tetrahydrocannabinol, the following isomers and their stereochemical variants |
7,8,9,10-tetrahydro-6,6,9-trimethyl- 3-pentyl-6H-dibenzo[b,d] pyran-1-ol (9R., 10aR)-8,9,10,10a-tetrahydro- 6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran-1-ol (6aR,9R,10aR)-6a,9,10,10a- tetrahydro-6,6,9-trimethyl-3- pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,10,10a-tetrahydro- 6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran-1-ol 6a,7,8,9-tetrahydro-6,6,9-trimethyl- 3-pentyl-6H-dibenzo[b,d] pyran-1-ol (6aR,10aR)-6a,7,8,9,10,10a-hexa- hydro-6,6-dimethyl-9-methylene- 3-pentyl-6H-dibenzo[b,d] pyran-1-ol |
|||
25. | TMA | (±)-3,4,5-trimethoxy-a-methylphen- ethylamine |
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.